Cannabis Law Report

JANUARY 30, 2019

To expand the number of manufacturers, the Drug Enforcement Administration (DEA) submitted a notice in the Federal Register on August 11, 2016, soliciting applications for licenses to manufacture marijuana for research purposes. However, over two years have passed without any new schedule I marijuana manufacturer registrations.

Research and Development 63

Research and Development DEA CBD Law 63

Canna Law Blog

AUGUST 31, 2023

Department of Health and Human Services (HHS) has officially recommended that marijuana be rescheduled, from Schedule I to Schedule III of the federal Controlled Substances Act (CSA). We’d like to see marijuana descheduled entirely, like alcohol or tobacco– which are demonstrably harmful substances. Huge news yesterday.

DEA 116

DEA Marijuana Banking Research and Development 116

Cannabis Law Report

MARCH 25, 2019

Ron Paul (R-TX) and Barney Frank (D-MA) introduced a bill to remove marijuana from the schedules entirely (“de-scheduling”). The Attorney General forwards the request to the Health and Human Services Secretary and requests a scientific and medical evaluation and recommendation, as specified by 23 USC 811(b-c). In 2011, Reps.

Banking 45

Banking Law Marijuana State Laws 45